MedPath

Efficacy and safety of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism inadequately controlled with cinacalcet

Not Applicable
Recruiting
Conditions
Secondary hyperparathyroidism
Registration Number
JPRN-UMIN000030568
Lead Sponsor
Jinken Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Corrected serum calcium <8.4 mg/dL Receiving hemodialysis less than three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath